Web28. jun 2024. · CARLSBAD, Calif., June 28, 2024 /PRNewswire/ -- Thermo Fisher Scientific today announced the launch of its Oncomine TCR Beta-SR Assay, a new next-generation sequencing (NGS) solution for immuno-oncology research designed to characterize T-cell clonality in the tumor microenvironment - a key approach to identify potential biomarkers … WebThe Oncomine TCR Pan-Clonality Assay specifically interrogates the CDR3 region of the T-cell receptor (TCR) beta and gamma chains. Detect low frequency T-cell clones in peripheral blood, with sensitivity down to 10-6. View Assay Details Somatic Hypermutation

Multidimensional NGS solutions enable tumor-immune insights …

WebOncomine TCR Beta-SR Assay 靶向T细胞受体TCR-β链的互补决定区3 (CDR3)，以表征免疫状态。 分析T细胞库并识别肿瘤部位的细胞毒性克隆体。 Oncomine TCR Beta-LR Assay 通过检测TCR-β链的CDR1、CDR2和CDR3，研究T细胞的免疫组库。 检测 TCR的趋同性，研究对免疫疗法的反应预测。 仅供科研使用，不可用于诊断目的。 WebOncomine TCR Beta-SR Assay は、免疫腫瘍学研究用の次世代シーケンサ（NGS）を用いたアッセイであり、TCR Beta の CDR3 領域の解析により、免疫状態の特徴を明ら … dead duck deducktion

Evaluation of therapeutic T cell manufacture using long amplicon …

WebThe Oncomine TCR Beta-SR Assay specifically interrogates the CDR3 region of the T-cell receptor (TCR) beta chain. In hemato-oncology research, this short-read sequencing assay enables detection of low frequency T-cell clones in … WebThe Ion AmpliSeq Immune Repertoire Assay Plus, TCR β, is comprehensive with up to 400 bp read-length amplicons for complete characterization of CDR1, CDR2, and CDR3 … WebThe Ion Torrent Oncomine BCR IGH LR Assay is a robust, targeted next-generation sequencing (NGS) assay designed for use in hematology-oncology, immuno-oncology, infectious disease, and basic immunology research. Unlike other technologies, the Oncomine BCR IGH-LR Assay offers more than 400 base amplicons of library … gender consultant in haiti in september 2022